Improved quality of life in cystic fibrosis patients observed up to 36 months after starting Elexacaftor/Tezacaftor/Ivacaftor treatment
Treatment with ETI significantly improved patients' QoL in both groups at 12-24 months, these improvements remaining stable in patients tested at 36 months.
Authors
- C. Marco
- Gloria Tridello
- Francesca Buniotto (ORCID: https://orcid.org/0009-0003-1189-1144)
- P. Sandra
- Pintani Emily
- De Scolari Antonella
- Meneghelli Ilaria
Institutions
- Cystic Fibrosis Research Foundation (IT)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1186/s41687-025-00879-0
- Citations
- 4
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 6.07